Sunshine Heart To Go Head To Head With Thoratec In NYHA Class III CHF Trials
An article published in the AHA journal in 2012 paints a concerning picture for incidences of bleeding during and after LVAD implantation ... likely domination of the NYHA Class III market, Sunshine Heart has far more medium- to long-term growth potential ...
Development of a Micro-integration Technique for the Fabrication of a Cell-Fiber Scaffold Complex in Heart Valve Tissue Engineering
More commonly ... The culture media used was Medium-199, supplemented with 20% fetal bovine serum (FBS) and antibiotics. During this period, cell maturing and proliferation was induced. Flow cytometry was then used to identify the CD133+.
Artículos originales con factor de impacto publicados o en presa en 2002
Impact of final coronary flow velocity ... something more than a simple molecular defect. Haematologica 87:562-563, 2002. IF: 3.216 78. Ruiz-Irastorza, G.; Khamashta, M. A.; Hunt, B. J.; Escudero, A.; Cuadrado, M. J. and Hughes, G. R. Bleeding and ...
Successful minimally-invasive management of a case of giant prostatic hypertrophy associated with recurrent nephrogenic adenoma of the prostate
He also described hesitancy and slow flow. No flow testing was performed at this time ... attempting to regenerate normal tubular tissues at their site of implantation. Certainly more work needs to be done to explore the specific growth factor environment ...
Individualized Dosing Using Platelet Function Testing: GRAVITAS
An important limitation of this study was the inclusion of patients who were predominantly low to medium risk with ... 2001–2015 (2007). • More powerful thienopyridine prevented thrombotic complications but induced greater bleeding when compared ...